{"count": 167, "results": [{"_id": "35480097", "pmid": 35480097, "pmcid": "PMC9035737", "title": "Metformin Regulates TET2 Expression to Inhibit Endometrial Carcinoma Proliferation: A New Mechanism", "journal": "Front Oncol", "authors": ["Zhang J", "Kuang L", "Li Y", "Wang Q", "Xu H", "Liu J", "Zhou X", "Li Y", "Zhang B"], "date": "2022-04-11T00:00:00Z", "doi": "10.3389/fonc.2022.856707", "meta_date_publication": "2022", "meta_volume": "12", "meta_issue": "", "meta_pages": "856707", "score": 50288.656, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Regulates @GENE_TET2 @GENE_54790 @@@TET2@@@ Expression to Inhibit @<m>DISEASE_Endometrial_Neoplasms</m> @DISEASE_MESH:D016889 @@@Endometrial Carcinoma@@@ Proliferation: A New Mechanism", "citations": {"NLM": "Zhang J, Kuang L, Li Y, Wang Q, Xu H, Liu J, Zhou X, Li Y, Zhang B. Metformin Regulates TET2 Expression to Inhibit Endometrial Carcinoma Proliferation: A New Mechanism Front Oncol. 2022;12():856707. PMID: 35480097", "BibTeX": "@article{35480097, title={Metformin Regulates TET2 Expression to Inhibit Endometrial Carcinoma Proliferation: A New Mechanism}, author={Zhang J and Kuang L and Li Y and Wang Q and Xu H and Liu J and Zhou X and Li Y and Zhang B}, journal={Front Oncol}, volume={12}, pages={856707}}"}}, {"_id": "37313172", "pmid": 37313172, "pmcid": "PMC10258389", "title": "Changes in the expression of cancer- and metastasis-related genes and proteins after metformin treatment under different metabolic conditions in endometrial cancer cells", "journal": "Heliyon", "authors": ["Lange C", "Brüggemann J", "Thüner T", "Jauckus J", "Strowitzki T", "Germeyer A"], "date": "2023-05-25T00:00:00Z", "doi": "10.1016/j.heliyon.2023.e16678", "meta_date_publication": "2023 Jun", "meta_volume": "9", "meta_issue": "6", "meta_pages": "e16678", "score": 50281.3, "text_hl": "Changes in the expression of @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@cancer@@@- @DISEASE_Neoplasm_Metastasis @DISEASE_MESH:D009362 @@@and metastasis@@@-related genes and proteins after @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment under different metabolic conditions in @<m>DISEASE_Endometrial_Neoplasms</m> @DISEASE_MESH:D016889 @@@endometrial cancer@@@ cells", "citations": {"NLM": "Lange C, Brüggemann J, Thüner T, Jauckus J, Strowitzki T, Germeyer A. Changes in the expression of cancer- and metastasis-related genes and proteins after metformin treatment under different metabolic conditions in endometrial cancer cells Heliyon. 2023 Jun;9(6):e16678. PMID: 37313172", "BibTeX": "@article{37313172, title={Changes in the expression of cancer- and metastasis-related genes and proteins after metformin treatment under different metabolic conditions in endometrial cancer cells}, author={Lange C and Brüggemann J and Thüner T and Jauckus J and Strowitzki T and Germeyer A}, journal={Heliyon}, volume={9}, number={6}, pages={e16678}}"}}, {"_id": "36226249", "pmid": 36226249, "pmcid": "PMC9550502", "title": "Metformin Exhibits an Attractive Antineoplastic Effect on Human Endometrial Cancer by Regulating the Hippo Signaling Pathway", "journal": "J Oncol", "authors": ["Wang M", "Zhang Q", "Li Y", "Jin L", "Fang Z"], "date": "2022-08-11T00:00:00Z", "doi": "10.1155/2022/5824617", "meta_date_publication": "2022", "meta_volume": "2022", "meta_issue": "", "meta_pages": "5824617", "score": 50280.855, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Exhibits an Attractive Antineoplastic Effect on @SPECIES_9606 @@@Human@@@ @<m>DISEASE_Endometrial_Neoplasms</m> @DISEASE_MESH:D016889 @@@Endometrial Cancer@@@ by Regulating the Hippo Signaling Pathway", "citations": {"NLM": "Wang M, Zhang Q, Li Y, Jin L, Fang Z. Metformin Exhibits an Attractive Antineoplastic Effect on Human Endometrial Cancer by Regulating the Hippo Signaling Pathway J Oncol. 2022;2022():5824617. PMID: 36226249", "BibTeX": "@article{36226249, title={Metformin Exhibits an Attractive Antineoplastic Effect on Human Endometrial Cancer by Regulating the Hippo Signaling Pathway}, author={Wang M and Zhang Q and Li Y and Jin L and Fang Z}, journal={J Oncol}, volume={2022}, pages={5824617}}"}}, {"_id": "36333773", "pmid": 36333773, "pmcid": "PMC9636609", "title": "Levonorgestrel-releasing intrauterine device plus metformin, or megestrol acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial carcinoma: a prospective, randomized, blind-endpoint design trial protocol", "journal": "Reprod Health", "authors": ["Zhao X", "Niu J", "Shi C", "Liu Z"], "date": "2022-11-04T00:00:00Z", "doi": "10.1186/s12978-022-01513-8", "meta_date_publication": "2022 Nov 4", "meta_volume": "19", "meta_issue": "1", "meta_pages": "206", "score": 50277.81, "text_hl": "Schuler et al. conducted a window of opportunity study in which 20 @<m>DISEASE_Endometrial_Neoplasms</m> @DISEASE_MESH:D016889 @@@EC@@@ @SPECIES_9606 @@@women@@@ were treated with 850 mg @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ once daily for 1-4 weeks before hysterectomy. ", "citations": {"NLM": "Zhao X, Niu J, Shi C, Liu Z. Levonorgestrel-releasing intrauterine device plus metformin, or megestrol acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial carcinoma: a prospective, randomized, blind-endpoint design trial protocol Reprod Health. 2022 Nov 4;19(1):206. PMID: 36333773", "BibTeX": "@article{36333773, title={Levonorgestrel-releasing intrauterine device plus metformin, or megestrol acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial carcinoma: a prospective, randomized, blind-endpoint design trial protocol}, author={Zhao X and Niu J and Shi C and Liu Z}, journal={Reprod Health}, volume={19}, number={1}, pages={206}}"}}, {"_id": "35052471", "pmid": 35052471, "pmcid": "PMC8775133", "title": "Diane-35 and Metformin Induce Autophagy and Apoptosis in Polycystic Ovary Syndrome Women with Early-Stage Endometrial Carcinoma", "journal": "Genes (Basel)", "authors": ["Liu Y", "Wang Y", "Yao D", "Chen X", "Zhang F", "Feng Y", "Li X"], "date": "2022-01-12T00:00:00Z", "doi": "10.3390/genes13010131", "meta_date_publication": "2022 Jan 12", "meta_volume": "13", "meta_issue": "1", "meta_pages": "", "score": 50276.695, "text_hl": "@CHEMICAL_Cyproterone_acetate_ethinyl_estradiol_drug_combination @CHEMICAL_MESH:C032640 @@@Diane-35@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Promote Apoptosis and Autophagy in @<m>DISEASE_Endometrial_Neoplasms</m> @DISEASE_MESH:D016889 @@@EC@@@ Cells", "citations": {"NLM": "Liu Y, Wang Y, Yao D, Chen X, Zhang F, Feng Y, Li X. Diane-35 and Metformin Induce Autophagy and Apoptosis in Polycystic Ovary Syndrome Women with Early-Stage Endometrial Carcinoma Genes (Basel). 2022 Jan 12;13(1):. PMID: 35052471", "BibTeX": "@article{35052471, title={Diane-35 and Metformin Induce Autophagy and Apoptosis in Polycystic Ovary Syndrome Women with Early-Stage Endometrial Carcinoma}, author={Liu Y and Wang Y and Yao D and Chen X and Zhang F and Feng Y and Li X}, journal={Genes (Basel)}, volume={13}, number={1}}"}}, {"_id": "32934724", "pmid": 32934724, "title": "Therapeutic effect of metformin in the treatment of endometrial cancer.", "journal": "Oncol Lett", "authors": ["Mu N", "Xu T", "Gao M", "Dong M", "Tang Q", "Hao L", "Wang G", "Li Z", "Wang W", "Yang Y", "Hou J"], "date": "2020-11-01T00:00:00Z", "doi": "10.3892/ol.2020.12017", "meta_date_publication": "2020 Nov", "meta_volume": "20", "meta_issue": "5", "meta_pages": "156", "score": 50274.766, "text_hl": "Therapeutic effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in the treatment of @<m>DISEASE_Endometrial_Neoplasms</m> @DISEASE_MESH:D016889 @@@endometrial cancer@@@.", "citations": {"NLM": "Mu N, Xu T, Gao M, Dong M, Tang Q, Hao L, Wang G, Li Z, Wang W, Yang Y, Hou J. Therapeutic effect of metformin in the treatment of endometrial cancer. Oncol Lett. 2020 Nov;20(5):156. PMID: 32934724", "BibTeX": "@article{32934724, title={Therapeutic effect of metformin in the treatment of endometrial cancer.}, author={Mu N and Xu T and Gao M and Dong M and Tang Q and Hao L and Wang G and Li Z and Wang W and Yang Y and Hou J}, journal={Oncol Lett}, volume={20}, number={5}, pages={156}}"}}, {"_id": "34422646", "pmid": 34422646, "pmcid": "PMC8377676", "title": "The Effects of NT-1044, a Novel AMPK Activator, on Endometrial Cancer Cell Proliferation, Apoptosis, Cell Stress and In Vivo Tumor Growth", "journal": "Front Oncol", "authors": ["Roque DR", "Zhang L", "Wysham WZ", "Han J", "Sun W", "Yin Y", "Livingston JN", "Batchelor KW", "Zhou C", "Bae-Jump VL"], "date": "2021-08-05T00:00:00Z", "doi": "10.3389/fonc.2021.690435", "meta_date_publication": "2021", "meta_volume": "11", "meta_issue": "", "meta_pages": "690435", "score": 50273.496, "text_hl": "As compared to placebo, NT-1044 and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ inhibited @<m>DISEASE_Endometrial_Neoplasms</m> @DISEASE_MESH:D016889 @@@endometrial tumor@@@ growth in @DISEASE_Obesity @DISEASE_MESH:D009765 @@@obese@@@ and lean LKB1fl/flp53fl/fl @SPECIES_10090 @@@mice@@@.", "citations": {"NLM": "Roque DR, Zhang L, Wysham WZ, Han J, Sun W, Yin Y, Livingston JN, Batchelor KW, Zhou C, Bae-Jump VL. The Effects of NT-1044, a Novel AMPK Activator, on Endometrial Cancer Cell Proliferation, Apoptosis, Cell Stress and In Vivo Tumor Growth Front Oncol. 2021;11():690435. PMID: 34422646", "BibTeX": "@article{34422646, title={The Effects of NT-1044, a Novel AMPK Activator, on Endometrial Cancer Cell Proliferation, Apoptosis, Cell Stress and In Vivo Tumor Growth}, author={Roque DR and Zhang L and Wysham WZ and Han J and Sun W and Yin Y and Livingston JN and Batchelor KW and Zhou C and Bae-Jump VL}, journal={Front Oncol}, volume={11}, pages={690435}}"}}, {"_id": "35341081", "pmid": 35341081, "pmcid": "PMC8932210", "title": "The Effect of Metformin on Expression of Long Non-coding RNA H19 in Endometrial Cancer", "journal": "Med J Islam Repub Iran", "authors": ["Aminimoghaddam S", "Fooladi B", "Noori M", "Nickhah Klashami Z", "Kakavand Hamidi A", "M Amoli M"], "date": "2021-11-22T00:00:00Z", "doi": "10.47176/mjiri.35.155", "meta_date_publication": "2021", "meta_volume": "35", "meta_issue": "", "meta_pages": "155", "score": 50272.66, "text_hl": "The Effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ on Expression of Long Non-coding RNA @GENE_H19 @GENE_283120 @@@H19@@@ in @<m>DISEASE_Endometrial_Neoplasms</m> @DISEASE_MESH:D016889 @@@Endometrial Cancer@@@", "citations": {"NLM": "Aminimoghaddam S, Fooladi B, Noori M, Nickhah Klashami Z, Kakavand Hamidi A, M Amoli M. The Effect of Metformin on Expression of Long Non-coding RNA H19 in Endometrial Cancer Med J Islam Repub Iran. 2021;35():155. PMID: 35341081", "BibTeX": "@article{35341081, title={The Effect of Metformin on Expression of Long Non-coding RNA H19 in Endometrial Cancer}, author={Aminimoghaddam S and Fooladi B and Noori M and Nickhah Klashami Z and Kakavand Hamidi A and M Amoli M}, journal={Med J Islam Repub Iran}, volume={35}, pages={155}}"}}, {"_id": "37415671", "pmid": 37415671, "pmcid": "PMC10320576", "title": "Progestin plus metformin improves outcomes in patients with endometrial hyperplasia and early endometrial cancer more than progestin alone: a meta-analysis", "journal": "Front Endocrinol (Lausanne)", "authors": ["Shao F", "Li Y", "Zhao Y"], "date": "2023-06-21T00:00:00Z", "doi": "10.3389/fendo.2023.1139858", "meta_date_publication": "2023", "meta_volume": "14", "meta_issue": "", "meta_pages": "1139858", "score": 50272.164, "text_hl": "Progestin plus @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ improves outcomes in @SPECIES_9606 @@@patients@@@ with @DISEASE_Endometrial_Hyperplasia @DISEASE_MESH:D004714 @@@endometrial hyperplasia@@@ and early @<m>DISEASE_Endometrial_Neoplasms</m> @DISEASE_MESH:D016889 @@@endometrial cancer@@@ more than progestin alone: a meta-analysis", "citations": {"NLM": "Shao F, Li Y, Zhao Y. Progestin plus metformin improves outcomes in patients with endometrial hyperplasia and early endometrial cancer more than progestin alone: a meta-analysis Front Endocrinol (Lausanne). 2023;14():1139858. PMID: 37415671", "BibTeX": "@article{37415671, title={Progestin plus metformin improves outcomes in patients with endometrial hyperplasia and early endometrial cancer more than progestin alone: a meta-analysis}, author={Shao F and Li Y and Zhao Y}, journal={Front Endocrinol (Lausanne)}, volume={14}, pages={1139858}}"}}, {"_id": "35898873", "pmid": 35898873, "pmcid": "PMC9309370", "title": "Association Between Metformin Use and the Risk, Prognosis of Gynecologic Cancer", "journal": "Front Oncol", "authors": ["Yao K", "Zheng H", "Li T"], "date": "2022-07-11T00:00:00Z", "doi": "10.3389/fonc.2022.942380", "meta_date_publication": "2022", "meta_volume": "12", "meta_issue": "", "meta_pages": "942380", "score": 50272.164, "text_hl": "Becker et al. reported that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ use and other antidiabetic drugs were not associated with an altered risk of @<m>DISEASE_Endometrial_Neoplasms</m> @DISEASE_MESH:D016889 @@@endometrial cancer@@@. ", "citations": {"NLM": "Yao K, Zheng H, Li T. Association Between Metformin Use and the Risk, Prognosis of Gynecologic Cancer Front Oncol. 2022;12():942380. PMID: 35898873", "BibTeX": "@article{35898873, title={Association Between Metformin Use and the Risk, Prognosis of Gynecologic Cancer}, author={Yao K and Zheng H and Li T}, journal={Front Oncol}, volume={12}, pages={942380}}"}}]}